Howard Liang - Jun 28, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
CFO & Chief Strategy Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Jun 28, 2021
Transactions value $
-$162,790
Form type
4
Date filed
6/30/2021, 04:45 PM
Previous filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Sale -$163K -446 -100% $365.00 0 Jun 28, 2021 Direct F1, F2
holding BGNE Ordinary Shares 1.55M Jun 28, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Howard Liang is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents 13 Ordinary Shares.
F2 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 26, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event.